InspireMD Inc Total Assets
InspireMD Inc total assets. Based on the latest financial reports, InspireMD Inc (NSPR) holds total assets worth $44.64 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see InspireMD Inc stock valuation for the company's overall valuation and market capitalisation.
Total Assets of InspireMD Inc (2008–2025)
Total assets of InspireMD Inc from 2008 to 2025. This chart illustrates how InspireMD Inc's total assets have evolved over time, based on quarterly financial data. See InspireMD Inc stock quote for real-time trading data and today's change.
InspireMD Inc - Asset Composition Analysis
InspireMD Inc Total Assets Breakdown (December 2025)
InspireMD Inc total assets breakdown as of December 2025. InspireMD Inc's total assets of $44.64 Million consist of 88.6% current assets and 11.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 12.9% |
| Accounts Receivable | $2.57 Million | 3.7% |
| Inventory | $3.40 Million | 4.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2008–2025)
This chart illustrates how InspireMD Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore NSPR working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: InspireMD Inc's current assets represent 88.6% of total assets in 2025, a decrease from 100.0% in 2008.
- Cash Position: Cash and equivalents constituted 12.9% of total assets in 2025, down from 100.0% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2008.
- Asset Diversification: The largest asset category is inventory at 4.9% of total assets.
InspireMD Inc Competitors by Total Assets
Key competitors of InspireMD Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
InspireMD Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.80 | 2.81 | 10.78 |
| Quick Ratio | 3.52 | 2.47 | 10.47 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $26.98 Million | $16.39 Million | $36.37 Million |
InspireMD Inc - Advanced Valuation Insights
This section examines the relationship between InspireMD Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.86 |
| Latest Market Cap to Assets Ratio | 0.44 |
| Asset Growth Rate (YoY) | 48.3% |
| Total Assets | $69.40 Million |
| Market Capitalization | $30.82 Million USD |
Valuation Analysis
Below Book Valuation: The market values InspireMD Inc's assets below their book value (0.44x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: InspireMD Inc's assets grew by 48.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for InspireMD Inc (2008–2025)
The table below shows the annual total assets of InspireMD Inc from 2008 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $69.40 Million | +48.28% |
| 2024-12-31 | $46.81 Million | -1.75% |
| 2023-12-31 | $47.64 Million | +93.25% |
| 2022-12-31 | $24.65 Million | -37.92% |
| 2021-12-31 | $39.71 Million | +123.39% |
| 2020-12-31 | $17.78 Million | +79.93% |
| 2019-12-31 | $9.88 Million | -19.60% |
| 2018-12-31 | $12.29 Million | +101.21% |
| 2017-12-31 | $6.11 Million | -35.10% |
| 2016-12-31 | $9.41 Million | +62.86% |
| 2015-12-31 | $5.78 Million | -49.58% |
| 2014-12-31 | $11.46 Million | -44.76% |
| 2013-12-31 | $20.75 Million | +29.54% |
| 2012-12-31 | $16.01 Million | +0.02% |
| 2012-06-30 | $16.01 Million | -0.02% |
| 2011-12-31 | $16.01 Million | +269314.54% |
| 2010-12-31 | $5.94K | 0.00% |
| 2009-12-31 | $5.94K | +20.69% |
| 2008-12-31 | $4.92K | -- |
About InspireMD Inc
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard c… Read more